Arkolith/Insider Trading/EKSO/Form 4

Sherman Steven

Executive Chair, DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Dec 7, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2022Option exercise(M)31K—$0739K
Dec 4, 2022Grant(A)243K—$0971K
Dec 4, 2022Sell(S)11K$1.28$14K729K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 4, 2022Option exercise(M)31K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001549084-22-000078) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML